News

Articles

Are we overlooking multi-target drugs?

Dr. Gelbard talks to STAT about multi-target drugs.

Revolutionizing Medical Research

Executive presentation

Following is an executive presentation by our Chief Science Officer, Dr. Harris Gelbard, providing background and due diligence input for potential use by investors who have requested information on the Company.

Download PDF

investor interest

We'll be happy to send you an investor packet once it has been published.

Please use the contact form on the Contact page to let us know of your interest.

Not so small print: We do not and will not sell your email address.

All investor interest will be kept strictly confidential.

Find out more

History

Pioneura received over $25 million funding from NIH and Foundations.

Website by: yda